These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26151925)

  • 1. Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.
    Frick A; Ahs F; Linnman C; Jonasson M; Appel L; Lubberink M; Långström B; Fredrikson M; Furmark T
    Transl Psychiatry; 2015 Jul; 5(7):e597. PubMed ID: 26151925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits.
    Hoppe JM; Frick A; Åhs F; Linnman C; Appel L; Jonasson M; Lubberink M; Långström B; Frans Ö; von Knorring L; Fredrikson M; Furmark T
    Transl Psychiatry; 2018 Aug; 8(1):168. PubMed ID: 30154470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system.
    Michelgård A; Appel L; Pissiota A; Frans O; Långström B; Bergström M; Fredrikson M
    Biol Psychiatry; 2007 Apr; 61(8):1002-6. PubMed ID: 16950220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11)C]GR205171.
    Danfors T; Åhs F; Appel L; Linnman C; Fredrikson M; Furmark T; Kumlien E
    Epilepsy Res; 2011 Nov; 97(1-2):183-9. PubMed ID: 21925840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.
    Frick A; Åhs F; Palmquist ÅM; Pissiota A; Wallenquist U; Fernandez M; Jonasson M; Appel L; Frans Ö; Lubberink M; Furmark T; von Knorring L; Fredrikson M
    Mol Psychiatry; 2016 Oct; 21(10):1400-7. PubMed ID: 26619809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
    Furmark T; Appel L; Michelgård A; Wahlstedt K; Ahs F; Zancan S; Jacobsson E; Flyckt K; Grohp M; Bergström M; Pich EM; Nilsson LG; Bani M; Långström B; Fredrikson M
    Biol Psychiatry; 2005 Jul; 58(2):132-42. PubMed ID: 16038684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, sex and NK1 receptors in the human brain -- a positron emission tomography study with [¹¹C]GR205171.
    Engman J; Åhs F; Furmark T; Linnman C; Pissiota A; Appel L; Frans Ö; Långström B; Fredrikson M
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):562-8. PubMed ID: 22225860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.
    Griffante C; Carletti R; Andreetta F; Corsi M
    Br J Pharmacol; 2006 May; 148(1):39-45. PubMed ID: 16501582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171--PET studies in rhesus monkey.
    Bergström M; Fasth KJ; Kilpatrick G; Ward P; Cable KM; Wipperman MD; Sutherland DR; Långström B
    Neuropharmacology; 2000 Feb; 39(4):664-70. PubMed ID: 10728887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.
    Nyman M; Eskola O; Kajander J; Jokinen R; Penttinen J; Karjalainen T; Nummenmaa L; Hirvonen J; Burns D; Hargreaves R; Solin O; Hietala J
    J Affect Disord; 2019 Jan; 242():188-194. PubMed ID: 30193189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
    Frick A; Åhs F; Appel L; Jonasson M; Wahlstedt K; Bani M; Merlo Pich E; Bettica P; Långström B; Lubberink M; Fredrikson M; Furmark T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1775-1783. PubMed ID: 27642077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.
    Syvänen S; Eriksson J; Genchel T; Lindhe O; Antoni G; Långström B
    BMC Med Imaging; 2007 Jul; 7():6. PubMed ID: 17663770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist.
    Hutson PH; Patel S; Jay MT; Barton CL
    Eur J Pharmacol; 2004 Jan; 484(1):57-64. PubMed ID: 14729382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ.
    Okumura M; Arakawa R; Ito H; Seki C; Takahashi H; Takano H; Haneda E; Nakao R; Suzuki H; Suzuki K; Okubo Y; Suhara T
    J Nucl Med; 2008 Nov; 49(11):1749-55. PubMed ID: 18927336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorder.
    Michelson D; Hargreaves R; Alexander R; Ceesay P; Hietala J; Lines C; Reines S
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):1-11. PubMed ID: 22433185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
    Etkin A; Wager TD
    Am J Psychiatry; 2007 Oct; 164(10):1476-88. PubMed ID: 17898336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.
    Ayanwuyi LO; Stopponi S; Ubaldi M; Cippitelli A; Nasuti C; Damadzic R; Heilig M; Schank J; Cheng K; Rice KC; Ciccocioppo R
    Br J Pharmacol; 2015 Nov; 172(21):5136-46. PubMed ID: 26275374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the rat.
    Kalinichev M; Bradford A; Bison S; Lucas A; Sartori I; Garbati N; Andreetta F; Bate S; Austin NE; Jones DN; Read KD; Alvaro G; Large CH
    Epilepsia; 2010 Aug; 51(8):1543-51. PubMed ID: 20067506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.